Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pharmacotherapy

Colchicine for recurrent pericarditis—what's new in CORP-2?

Nature Reviews Cardiology volume 11, pages 376–378 (2014)Cite this article

Subjects

In the CORP-2 trial, patients with multiple recurrences of idiopathic or autoimmune pericarditis were randomly assigned to receive colchicine or placebo, in addition to standard anti-inflammatory therapy. After 6 months, colchicine significantly reduced recurrent pericarditis rates. Are we moving closer to a reliable treatment for this common disease?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Imazio, M. et al. A randomized trial of colchicine for acute pericarditis. N. Engl. J. Med. 369, 1522–1528 (2013).

    Article  CAS  PubMed  Google Scholar 

  2. Imazio, M. et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann. Intern. Med. 155, 409–414 (2011).

    Article  PubMed  Google Scholar 

  3. Imazio, M. et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet http://dx.doi.org/10.1016/S0140–6736(13)62709–9.

  4. Syed, F. F., Ntsekhe, M. & Mayosi, B. M. Tailoring diagnosis and management of pericardial disease to the epidemiological setting. Mayo Clin. Proc. 85, 866 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Imazio, M. et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 124, 1270–1275 (2011).

    Article  PubMed  Google Scholar 

  6. Imazio, M. et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am. J. Cardiol. 100, 1026–1028 (2007).

    Article  PubMed  Google Scholar 

  7. Brucato, A. et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol. 98, 267–271 (2006).

    Article  PubMed  Google Scholar 

  8. Ntsekhe, M. et al. Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion. PLoS ONE 8, e77532 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Feng, D. et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation 124, 1830–1837 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Finetti, M. et al. Long-term efficacy of interleukin-1 receptor antagonist (Anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J. Pediatr. http://dx.doi.org/10.1016/j/peds.2014.01.065.

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, 55905, MN, USA

    Faisal F. Syed

  2. Department of Medicine, University of Cape Town, J Floor Old Main Building, Groote Schuur Hospital, Observatory, 7925, Cape Town, South Africa

    Bongani M. Mayosi

Authors
  1. Faisal F. Syed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bongani M. Mayosi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bongani M. Mayosi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Syed, F., Mayosi, B. Colchicine for recurrent pericarditis—what's new in CORP-2?. Nat Rev Cardiol 11, 376–378 (2014). https://doi.org/10.1038/nrcardio.2014.71

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2014.71

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing